Li Cailan, Tang Ying, Ye Yonghao, Zuo Manhua, Lu Qiang
Department of Pharmacology, Zunyi Medical University, Zhuhai Campus, Zhuhai, China.
Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, China.
Front Pharmacol. 2023 Mar 3;14:1120616. doi: 10.3389/fphar.2023.1120616. eCollection 2023.
Ulcerative colitis (UC) is an inflammatory bowel disease generally characterized by chronic, persistent, recurrent, and non-specific ulcers of the intestine. Its main clinical manifestations include abdominal pain, diarrhea, and bloody stools. This disease is difficult to cure and even carries the risk of canceration. It has been listed as a modern refractory disease by the World Health Organization. Though a large amount of drugs are available for the inhibition of UC, the conventional treatment such as aminosalicylic acids, glucocorticoids, immunosuppressors, and biological agents possess certain limitations and serious side effects. Therefore, it is urgently needed for safe and effective drugs of UC, and natural-derived flavonols and flavanones showed tremendous potential. The present study concentrated on the progress of natural-derived flavonols and flavanones from edible and pharmaceutical plants for the remedy of UC over the last two decades. The potential pharmaceutical of natural-derived flavonols and flavanones against UC were closely connected with the modulation of gut microflora, gut barrier function, inflammatory reactions, oxidative stress, and apoptosis. The excellent efficacy and safety of natural flavonols and flavanones make them prospective drug candidates for UC suppression.
溃疡性结肠炎(UC)是一种炎症性肠病,通常以肠道的慢性、持续性、复发性和非特异性溃疡为特征。其主要临床表现包括腹痛、腹泻和便血。这种疾病难以治愈,甚至有癌变风险。它已被世界卫生组织列为现代难治性疾病。尽管有大量药物可用于抑制UC,但传统治疗方法如氨基水杨酸类、糖皮质激素、免疫抑制剂和生物制剂存在一定局限性和严重副作用。因此,迫切需要治疗UC的安全有效药物,而天然来源的黄酮醇和黄烷酮显示出巨大潜力。本研究聚焦于过去二十年中来自食用和药用植物的天然来源黄酮醇和黄烷酮在治疗UC方面的进展。天然来源黄酮醇和黄烷酮对UC的潜在药理作用与肠道微生物群调节、肠道屏障功能、炎症反应、氧化应激和细胞凋亡密切相关。天然黄酮醇和黄烷酮的优异疗效和安全性使其成为抑制UC的潜在候选药物。